Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vomiting 1Nausea 1Gastrointestinal Neoplasms 1

Interventions

Aprepitant 8Dexamethasone 7Calcium Dobesilate 7Ondansetron 6dexamethasone acetate 5Therapeutics 5Doxorubicin 5Vincristine 4Palonosetron 4Cyclophosphamide 4dexamethasone 21-phosphate 3Psychiatric Rehabilitation 3Granisetron 3peppermint oil 2auricularum 2Yoga 2Rituximab 2Music Therapy 2Mesna 2Lorazepam 2Ifosfamide 2Control Groups 2Aromatherapy 2Acupressure 2stinging nettle lectin 1salicylhydroxamic acid 1fosaprepitant 1dolasetron 1almond oil 1Whole Body Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Nausea × dolasetron × Clear all
NCT02550119 2017-03-28

Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancy

University of Southern California

Phase NA Terminated
19 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡